Application 212038
- Type
- NDA
- Sponsor
- PURDUE PHARMA LP
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ADHANSIA XR | METHYLPHENIDATE HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | 25MG | Yes | No |
| 002 | ADHANSIA XR | METHYLPHENIDATE HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | 35MG | Yes | No |
| 003 | ADHANSIA XR | METHYLPHENIDATE HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | 45MG | Yes | No |
| 004 | ADHANSIA XR | METHYLPHENIDATE HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | 55MG | Yes | No |
| 005 | ADHANSIA XR | METHYLPHENIDATE HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | 70MG | Yes | No |
| 006 | ADHANSIA XR | METHYLPHENIDATE HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | 85MG | Yes | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N212038-001 | ADHANSIA XR | METHYLPHENIDATE HYDROCHLORIDE | 25MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2019-02-27 | |
| N212038-002 | ADHANSIA XR | METHYLPHENIDATE HYDROCHLORIDE | 35MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2019-02-27 | |
| N212038-003 | ADHANSIA XR | METHYLPHENIDATE HYDROCHLORIDE | 45MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2019-02-27 | |
| N212038-004 | ADHANSIA XR | METHYLPHENIDATE HYDROCHLORIDE | 55MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2019-02-27 | |
| N212038-005 | ADHANSIA XR | METHYLPHENIDATE HYDROCHLORIDE | 70MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2019-02-27 | |
| N212038-006 | ADHANSIA XR | METHYLPHENIDATE HYDROCHLORIDE | 85MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2019-02-27 |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N212038-001 | 10111839 | 2035-10-30 | U-2357 | 2019-03-08 | |
| N212038-001 | 10292938 | 2035-10-30 | Drug product | 2019-05-22 | |
| N212038-001 | 10292939 | 2035-10-30 | U-2357 | Drug product | 2019-05-22 |
| N212038-001 | 10449159 | 2035-10-30 | U-2357 | 2019-10-22 | |
| N212038-001 | 10500162 | 2035-10-30 | U-2357 | 2019-12-11 | |
| N212038-001 | 10507186 | 2035-10-30 | Drug product | 2019-12-18 | |
| N212038-001 | 10512612 | 2035-10-30 | Drug product | 2020-01-02 | |
| N212038-001 | 10512613 | 2035-10-30 | U-2357 | 2020-01-02 | |
| N212038-001 | 10568841 | 2035-10-30 | U-2357 | Drug product | 2020-02-26 |
| N212038-001 | 10688060 | 2035-10-30 | Drug product | 2020-06-23 | |
| N212038-001 | 9974752 | 2035-10-30 | Drug product | 2019-03-08 | |
| N212038-001 | 10722473 | 2038-11-19 | U-2357 | 2020-07-28 | |
| N212038-002 | 10111839 | 2035-10-30 | U-2357 | 2019-03-08 | |
| N212038-002 | 10292938 | 2035-10-30 | Drug product | 2019-05-22 | |
| N212038-002 | 10292939 | 2035-10-30 | U-2357 | Drug product | 2019-05-22 |
| N212038-002 | 10449159 | 2035-10-30 | U-2357 | 2019-10-22 | |
| N212038-002 | 10500162 | 2035-10-30 | U-2357 | 2019-12-11 | |
| N212038-002 | 10507186 | 2035-10-30 | Drug product | 2019-12-18 | |
| N212038-002 | 10512612 | 2035-10-30 | Drug product | 2020-01-02 | |
| N212038-002 | 10512613 | 2035-10-30 | U-2357 | 2020-01-02 | |
| N212038-002 | 10568841 | 2035-10-30 | U-2357 | Drug product | 2020-02-26 |
| N212038-002 | 10688060 | 2035-10-30 | Drug product | 2020-06-23 | |
| N212038-002 | 9974752 | 2035-10-30 | Drug product | 2019-03-08 | |
| N212038-002 | 10722473 | 2038-11-19 | U-2357 | 2020-07-28 | |
| N212038-003 | 10111839 | 2035-10-30 | U-2357 | 2019-03-08 | |
| N212038-003 | 10292938 | 2035-10-30 | Drug product | 2019-05-22 | |
| N212038-003 | 10292939 | 2035-10-30 | U-2357 | Drug product | 2019-05-22 |
| N212038-003 | 10449159 | 2035-10-30 | U-2357 | 2019-10-22 | |
| N212038-003 | 10500162 | 2035-10-30 | U-2357 | 2019-12-11 | |
| N212038-003 | 10507186 | 2035-10-30 | Drug product | 2019-12-18 | |
| N212038-003 | 10512612 | 2035-10-30 | Drug product | 2020-01-02 | |
| N212038-003 | 10512613 | 2035-10-30 | U-2357 | 2020-01-02 | |
| N212038-003 | 10568841 | 2035-10-30 | U-2357 | Drug product | 2020-02-26 |
| N212038-003 | 10688060 | 2035-10-30 | Drug product | 2020-06-23 | |
| N212038-003 | 9974752 | 2035-10-30 | Drug product | 2019-03-08 | |
| N212038-003 | 10722473 | 2038-11-19 | U-2357 | 2020-07-28 | |
| N212038-004 | 10111839 | 2035-10-30 | U-2357 | 2019-03-08 | |
| N212038-004 | 10292938 | 2035-10-30 | Drug product | 2019-05-22 | |
| N212038-004 | 10292939 | 2035-10-30 | U-2357 | Drug product | 2019-05-22 |
| N212038-004 | 10449159 | 2035-10-30 | U-2357 | 2019-10-22 | |
| N212038-004 | 10500162 | 2035-10-30 | U-2357 | 2019-12-11 | |
| N212038-004 | 10507186 | 2035-10-30 | Drug product | 2019-12-18 | |
| N212038-004 | 10512612 | 2035-10-30 | Drug product | 2020-01-02 | |
| N212038-004 | 10512613 | 2035-10-30 | U-2357 | 2020-01-02 | |
| N212038-004 | 10568841 | 2035-10-30 | U-2357 | Drug product | 2020-02-26 |
| N212038-004 | 10688060 | 2035-10-30 | Drug product | 2020-06-23 | |
| N212038-004 | 9974752 | 2035-10-30 | Drug product | 2019-03-08 | |
| N212038-004 | 10722473 | 2038-11-19 | U-2357 | 2020-07-28 | |
| N212038-005 | 10111839 | 2035-10-30 | U-2357 | 2019-03-08 | |
| N212038-005 | 10292938 | 2035-10-30 | Drug product | 2019-05-22 | |
| N212038-005 | 10292939 | 2035-10-30 | U-2357 | Drug product | 2019-05-22 |
| N212038-005 | 10449159 | 2035-10-30 | U-2357 | 2019-10-22 | |
| N212038-005 | 10500162 | 2035-10-30 | U-2357 | 2019-12-11 | |
| N212038-005 | 10507186 | 2035-10-30 | Drug product | 2019-12-18 | |
| N212038-005 | 10512612 | 2035-10-30 | Drug product | 2020-01-02 | |
| N212038-005 | 10512613 | 2035-10-30 | U-2357 | 2020-01-02 | |
| N212038-005 | 10568841 | 2035-10-30 | U-2357 | Drug product | 2020-02-26 |
| N212038-005 | 10688060 | 2035-10-30 | Drug product | 2020-06-23 | |
| N212038-005 | 9974752 | 2035-10-30 | Drug product | 2019-03-08 | |
| N212038-005 | 10722473 | 2038-11-19 | U-2357 | 2020-07-28 | |
| N212038-006 | 10111839 | 2035-10-30 | U-2357 | 2019-03-08 | |
| N212038-006 | 10292938 | 2035-10-30 | Drug product | 2019-05-22 | |
| N212038-006 | 10292939 | 2035-10-30 | U-2357 | Drug product | 2019-05-22 |
| N212038-006 | 10449159 | 2035-10-30 | U-2357 | 2019-10-22 | |
| N212038-006 | 10500162 | 2035-10-30 | U-2357 | 2019-12-11 | |
| N212038-006 | 10507186 | 2035-10-30 | Drug product | 2019-12-18 | |
| N212038-006 | 10512612 | 2035-10-30 | Drug product | 2020-01-02 | |
| N212038-006 | 10512613 | 2035-10-30 | U-2357 | 2020-01-02 | |
| N212038-006 | 10568841 | 2035-10-30 | U-2357 | Drug product | 2020-02-26 |
| N212038-006 | 10688060 | 2035-10-30 | Drug product | 2020-06-23 | |
| N212038-006 | 9974752 | 2035-10-30 | Drug product | 2019-03-08 | |
| N212038-006 | 10722473 | 2038-11-19 | U-2357 | 2020-07-28 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N212038-001 | ADHANSIA XR | 25MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2019-02-27 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N212038-002 | ADHANSIA XR | 35MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2019-02-27 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N212038-003 | ADHANSIA XR | 45MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2019-02-27 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N212038-004 | ADHANSIA XR | 55MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2019-02-27 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N212038-005 | ADHANSIA XR | 70MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2019-02-27 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N212038-006 | ADHANSIA XR | 85MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2019-02-27 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N212038-001 | ADHANSIA XR | 25MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2019-02-27 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N212038-002 | ADHANSIA XR | 35MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2019-02-27 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N212038-003 | ADHANSIA XR | 45MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2019-02-27 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N212038-004 | ADHANSIA XR | 55MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2019-02-27 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N212038-005 | ADHANSIA XR | 70MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2019-02-27 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N212038-006 | ADHANSIA XR | 85MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2019-02-27 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N212038-001 | ADHANSIA XR | 25MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2019-02-27 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N212038-002 | ADHANSIA XR | 35MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2019-02-27 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N212038-003 | ADHANSIA XR | 45MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2019-02-27 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N212038-004 | ADHANSIA XR | 55MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2019-02-27 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N212038-005 | ADHANSIA XR | 70MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2019-02-27 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N212038-006 | ADHANSIA XR | 85MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2019-02-27 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N212038-001 | ADHANSIA XR | 25MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2019-02-27 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N212038-002 | ADHANSIA XR | 35MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2019-02-27 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N212038-003 | ADHANSIA XR | 45MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2019-02-27 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N212038-004 | ADHANSIA XR | 55MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2019-02-27 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N212038-005 | ADHANSIA XR | 70MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2019-02-27 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N212038-006 | ADHANSIA XR | 85MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2019-02-27 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N212038-001 | ADHANSIA XR | 25MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2019-02-27 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N212038-002 | ADHANSIA XR | 35MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2019-02-27 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N212038-003 | ADHANSIA XR | 45MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2019-02-27 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N212038-004 | ADHANSIA XR | 55MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2019-02-27 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N212038-005 | ADHANSIA XR | 70MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2019-02-27 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N212038-006 | ADHANSIA XR | 85MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2019-02-27 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N212038-001 | ADHANSIA XR | 25MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2019-02-27 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N212038-002 | ADHANSIA XR | 35MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2019-02-27 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N212038-003 | ADHANSIA XR | 45MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2019-02-27 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N212038-004 | ADHANSIA XR | 55MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2019-02-27 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N212038-005 | ADHANSIA XR | 70MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2019-02-27 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N212038-006 | ADHANSIA XR | 85MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2019-02-27 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N212038-001 | ADHANSIA XR | 25MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2019-02-27 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N212038-002 | ADHANSIA XR | 35MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2019-02-27 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N212038-003 | ADHANSIA XR | 45MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2019-02-27 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N212038-004 | ADHANSIA XR | 55MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2019-02-27 | b8a1b40f171c… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N212038-001 | 10111839 | 2035-10-30 | U-2357 | 2019-03-08 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N212038-001 | 10292938 | 2035-10-30 | Drug product | 2019-05-22 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N212038-001 | 10292939 | 2035-10-30 | U-2357 | Drug product | 2019-05-22 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N212038-001 | 10449159 | 2035-10-30 | U-2357 | 2019-10-22 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N212038-001 | 10500162 | 2035-10-30 | U-2357 | 2019-12-11 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N212038-001 | 10507186 | 2035-10-30 | Drug product | 2019-12-18 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N212038-001 | 10512612 | 2035-10-30 | Drug product | 2020-01-02 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N212038-001 | 10512613 | 2035-10-30 | U-2357 | 2020-01-02 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N212038-001 | 10568841 | 2035-10-30 | U-2357 | Drug product | 2020-02-26 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N212038-001 | 10688060 | 2035-10-30 | Drug product | 2020-06-23 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N212038-001 | 9974752 | 2035-10-30 | Drug product | 2019-03-08 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N212038-001 | 10722473 | 2038-11-19 | U-2357 | 2020-07-28 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N212038-002 | 10111839 | 2035-10-30 | U-2357 | 2019-03-08 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N212038-002 | 10292938 | 2035-10-30 | Drug product | 2019-05-22 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N212038-002 | 10292939 | 2035-10-30 | U-2357 | Drug product | 2019-05-22 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N212038-002 | 10449159 | 2035-10-30 | U-2357 | 2019-10-22 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N212038-002 | 10500162 | 2035-10-30 | U-2357 | 2019-12-11 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N212038-002 | 10507186 | 2035-10-30 | Drug product | 2019-12-18 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N212038-002 | 10512612 | 2035-10-30 | Drug product | 2020-01-02 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N212038-002 | 10512613 | 2035-10-30 | U-2357 | 2020-01-02 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N212038-002 | 10568841 | 2035-10-30 | U-2357 | Drug product | 2020-02-26 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N212038-002 | 10688060 | 2035-10-30 | Drug product | 2020-06-23 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N212038-002 | 9974752 | 2035-10-30 | Drug product | 2019-03-08 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N212038-002 | 10722473 | 2038-11-19 | U-2357 | 2020-07-28 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N212038-003 | 10111839 | 2035-10-30 | U-2357 | 2019-03-08 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N212038-003 | 10292938 | 2035-10-30 | Drug product | 2019-05-22 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N212038-003 | 10292939 | 2035-10-30 | U-2357 | Drug product | 2019-05-22 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N212038-003 | 10449159 | 2035-10-30 | U-2357 | 2019-10-22 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N212038-003 | 10500162 | 2035-10-30 | U-2357 | 2019-12-11 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N212038-003 | 10507186 | 2035-10-30 | Drug product | 2019-12-18 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N212038-003 | 10512612 | 2035-10-30 | Drug product | 2020-01-02 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N212038-003 | 10512613 | 2035-10-30 | U-2357 | 2020-01-02 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N212038-003 | 10568841 | 2035-10-30 | U-2357 | Drug product | 2020-02-26 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N212038-003 | 10688060 | 2035-10-30 | Drug product | 2020-06-23 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N212038-003 | 9974752 | 2035-10-30 | Drug product | 2019-03-08 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N212038-003 | 10722473 | 2038-11-19 | U-2357 | 2020-07-28 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N212038-004 | 10111839 | 2035-10-30 | U-2357 | 2019-03-08 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N212038-004 | 10292938 | 2035-10-30 | Drug product | 2019-05-22 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N212038-004 | 10292939 | 2035-10-30 | U-2357 | Drug product | 2019-05-22 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N212038-004 | 10449159 | 2035-10-30 | U-2357 | 2019-10-22 | 84e616aacf4f… |
Observed Orange Book exclusivity history#
| Captured | Edition | Application-product | Exclusivity code | Expiration | Source SHA-256 |
|---|---|---|---|---|---|
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N212038-001 | M-82 | 2024-06-28 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N212038-002 | M-82 | 2024-06-28 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N212038-003 | M-82 | 2024-06-28 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N212038-004 | M-82 | 2024-06-28 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N212038-005 | M-82 | 2024-06-28 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N212038-006 | M-82 | 2024-06-28 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N212038-001 | M-82 | 2024-06-28 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N212038-002 | M-82 | 2024-06-28 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N212038-003 | M-82 | 2024-06-28 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N212038-004 | M-82 | 2024-06-28 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N212038-005 | M-82 | 2024-06-28 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N212038-006 | M-82 | 2024-06-28 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N212038-001 | M-82 | 2024-06-28 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N212038-002 | M-82 | 2024-06-28 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N212038-003 | M-82 | 2024-06-28 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N212038-004 | M-82 | 2024-06-28 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N212038-005 | M-82 | 2024-06-28 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N212038-006 | M-82 | 2024-06-28 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N212038-001 | M-82 | 2024-06-28 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N212038-002 | M-82 | 2024-06-28 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N212038-003 | M-82 | 2024-06-28 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N212038-004 | M-82 | 2024-06-28 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N212038-005 | M-82 | 2024-06-28 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N212038-006 | M-82 | 2024-06-28 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | N212038-001 | M-82 | 2024-06-28 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | N212038-002 | M-82 | 2024-06-28 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | N212038-003 | M-82 | 2024-06-28 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | N212038-004 | M-82 | 2024-06-28 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | N212038-005 | M-82 | 2024-06-28 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | N212038-006 | M-82 | 2024-06-28 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N212038-001 | M-82 | 2024-06-28 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N212038-002 | M-82 | 2024-06-28 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N212038-003 | M-82 | 2024-06-28 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N212038-004 | M-82 | 2024-06-28 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N212038-005 | M-82 | 2024-06-28 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N212038-006 | M-82 | 2024-06-28 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N212038-001 | M-82 | 2024-06-28 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N212038-002 | M-82 | 2024-06-28 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N212038-003 | M-82 | 2024-06-28 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N212038-004 | M-82 | 2024-06-28 | 301d65b070ca… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Methylphenidate Hydrochloride | METHYLPHENIDATE HYDROCHLORIDE | Lupin Pharmaceuticals,Inc. | 57fd619e-687d-403c-a77a-3dc3a1bab65a | 2023-12-11 | Boxed warning, Warnings, Adverse reactions | METHYLPHENIDATE HYDROCHLORIDE |
| Methylphenidate Hydrochloride | METHYLPHENIDATE HYDROCHLORIDE | Lupin Pharmaceuticals,Inc. | 5bfe50ed-171f-4c40-bc0b-20c68e8e2025 | 2023-12-11 | Boxed warning, Warnings, Adverse reactions | METHYLPHENIDATE HYDROCHLORIDE |
| Methylphenidate Hydrochloride | METHYLPHENIDATE HYDROCHLORIDE | Eywa Pharma Inc | 298fb86d-7d94-49e1-b743-3e7801122422 | 2023-11-08 | Boxed warning, Warnings, Adverse reactions | METHYLPHENIDATE HYDROCHLORIDE |
| Methylin | METHYLPHENIDATE HYDROCHLORIDE | SHIONOGI INC. | 9e3c22d9-71d9-46a7-b315-8021c94c4bec | 2023-11-01 | Boxed warning, Warnings, Adverse reactions | METHYLPHENIDATE HYDROCHLORIDE |
| Methylphenidate Hydrochloride | METHYLPHENIDATE HYDROCHLORIDE | SpecGx LLC | 981a2ad8-33f7-4678-9162-9df9685bd4a6 | 2023-10-01 | Boxed warning, Warnings, Adverse reactions | METHYLPHENIDATE HYDROCHLORIDE |
| Methylphenidate Hydrochloride | METHYLPHENIDATE HYDROCHLORIDE | XLCare Pharmaceuticals, Inc. | 91833146-fa95-471a-8b8d-6d36a2db5c9a | 2023-09-28 | Boxed warning, Warnings, Adverse reactions | METHYLPHENIDATE HYDROCHLORIDE |
| Methylphenidate Hydrochloride | METHYLPHENIDATE HYDROCHLORIDE | Camber Pharmaceuticals Inc. | bb73cd3e-aa7c-4f7e-826d-75e71fb6d1e0 | 2023-09-27 | Boxed warning, Warnings, Adverse reactions | METHYLPHENIDATE HYDROCHLORIDE |
| METHYLPHENIDATE HYDROCHLORIDE | METHYLPHENIDATE HYDROCHLORIDE | QUAGEN PHARMACEUTICALS LLC | 59de488c-c3f8-415d-9e9f-9102c090aac8 | 2023-02-02 | Boxed warning, Warnings, Adverse reactions | METHYLPHENIDATE HYDROCHLORIDE |
| Methylphenidate Hydrochloride | METHYLPHENIDATE HYDROCHLORIDE | Ascend Laboratories, LLC | 5fa3da25-13aa-4ee3-acf5-cd505f4688d0 | 2021-12-29 | Boxed warning, Warnings, Adverse reactions | METHYLPHENIDATE HYDROCHLORIDE |
| Methylphenidate Hydrochloride | METHYLPHENIDATE HYDROCHLORIDE | Dr.Reddys Laboratories Inc | 7124df7e-6273-a68d-6e35-dc06122d8686 | 2021-12-03 | Boxed warning, Warnings, Adverse reactions | METHYLPHENIDATE HYDROCHLORIDE |
| METHYLPHENIDATE HYDROCHLORIDE | METHYLPHENIDATE HYDROCHLORIDE | XLCare Pharmaceuticals Inc | 94dc74d4-b4ef-45bc-b502-54ec692e9bd5 | 2021-08-18 | Boxed warning, Warnings, Adverse reactions | METHYLPHENIDATE HYDROCHLORIDE |
| Methylphenidate Hydrochloride | METHYLPHENIDATE HYDROCHLORIDE | Camber Pharmaceuticals, Inc. | b9af3104-172d-4975-9301-b9fe7db9ef12 | 2021-08-17 | Boxed warning, Warnings, Adverse reactions | METHYLPHENIDATE HYDROCHLORIDE |
| Methylphenidate Hydrochloride | METHYLPHENIDATE HYDROCHLORIDE | XLCare Pharmaceuticals, Inc. | b07150db-fd99-4400-bb83-b3a7544a917a | 2021-08-17 | Boxed warning, Warnings, Adverse reactions | METHYLPHENIDATE HYDROCHLORIDE |
| Methylphenidate Hydrochloride | METHYLPHENIDATE HYDROCHLORIDE | Ascent Pharmaceuticals, Inc. | 45ebb59c-9603-4df6-b1be-3295ba2db1e7 | 2021-01-29 | Warnings, Adverse reactions | METHYLPHENIDATE HYDROCHLORIDE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 72912-525 | ADHANSIA XR | methylphenidate hydrochloride | Adlon Therapeutics L.P. | NDA | Current |
| 72912-525 | ADHANSIA XR | methylphenidate hydrochloride | Adlon Therapeutics L.P. | NDA | Current |
| 72912-525 | ADHANSIA XR | methylphenidate hydrochloride Extented Release Capsules | Adlon Therapeutics L.P. | NDA | Current |
| 72912-525 | ADHANSIA XR | methylphenidate hydrochloride | Adlon Therapeutics L.P. | NDA | Current |
| 72912-525 | ADHANSIA XR | methylphenidate hydrochloride | Adlon Therapeutics L.P. | NDA | Current |
| 72912-525 | ADHANSIA XR | methylphenidate hydrochloride | Adlon Therapeutics L.P. | NDA | Current |
| 72912-525 | ADHANSIA XR | methylphenidate hydrochloride | Adlon Therapeutics L.P. | NDA | Current |
| 72912-525 | ADHANSIA XR | methylphenidate hydrochloride | Adlon Therapeutics L.P. | NDA | Current |
| 72912-535 | ADHANSIA XR | methylphenidate hydrochloride | Adlon Therapeutics L.P. | NDA | Current |
| 72912-535 | ADHANSIA XR | methylphenidate hydrochloride | Adlon Therapeutics L.P. | NDA | Current |
| 72912-535 | ADHANSIA XR | methylphenidate hydrochloride Extented Release Capsules | Adlon Therapeutics L.P. | NDA | Current |
| 72912-535 | ADHANSIA XR | methylphenidate hydrochloride | Adlon Therapeutics L.P. | NDA | Current |
| 72912-535 | ADHANSIA XR | methylphenidate hydrochloride | Adlon Therapeutics L.P. | NDA | Current |
| 72912-535 | ADHANSIA XR | methylphenidate hydrochloride | Adlon Therapeutics L.P. | NDA | Current |
| 72912-535 | ADHANSIA XR | methylphenidate hydrochloride | Adlon Therapeutics L.P. | NDA | Current |
| 72912-535 | ADHANSIA XR | methylphenidate hydrochloride | Adlon Therapeutics L.P. | NDA | Current |
| 72912-545 | ADHANSIA XR | methylphenidate hydrochloride | Adlon Therapeutics L.P. | NDA | Current |
| 72912-545 | ADHANSIA XR | methylphenidate hydrochloride | Adlon Therapeutics L.P. | NDA | Current |
| 72912-545 | ADHANSIA XR | methylphenidate hydrochloride Extented Release Capsules | Adlon Therapeutics L.P. | NDA | Current |
| 72912-545 | ADHANSIA XR | methylphenidate hydrochloride | Adlon Therapeutics L.P. | NDA | Current |
| 72912-545 | ADHANSIA XR | methylphenidate hydrochloride | Adlon Therapeutics L.P. | NDA | Current |
| 72912-545 | ADHANSIA XR | methylphenidate hydrochloride | Adlon Therapeutics L.P. | NDA | Current |
| 72912-545 | ADHANSIA XR | methylphenidate hydrochloride | Adlon Therapeutics L.P. | NDA | Current |
| 72912-545 | ADHANSIA XR | methylphenidate hydrochloride | Adlon Therapeutics L.P. | NDA | Current |
| 72912-555 | ADHANSIA XR | methylphenidate hydrochloride | Adlon Therapeutics L.P. | NDA | Current |
| 72912-555 | ADHANSIA XR | methylphenidate hydrochloride | Adlon Therapeutics L.P. | NDA | Current |
| 72912-555 | ADHANSIA XR | methylphenidate hydrochloride Extented Release Capsules | Adlon Therapeutics L.P. | NDA | Current |
| 72912-555 | ADHANSIA XR | methylphenidate hydrochloride | Adlon Therapeutics L.P. | NDA | Current |
| 72912-555 | ADHANSIA XR | methylphenidate hydrochloride | Adlon Therapeutics L.P. | NDA | Current |
| 72912-555 | ADHANSIA XR | methylphenidate hydrochloride | Adlon Therapeutics L.P. | NDA | Current |
| 72912-555 | ADHANSIA XR | methylphenidate hydrochloride | Adlon Therapeutics L.P. | NDA | Current |
| 72912-555 | ADHANSIA XR | methylphenidate hydrochloride | Adlon Therapeutics L.P. | NDA | Current |
| 72912-570 | ADHANSIA XR | methylphenidate hydrochloride | Adlon Therapeutics L.P. | NDA | Current |
| 72912-570 | ADHANSIA XR | methylphenidate hydrochloride | Adlon Therapeutics L.P. | NDA | Current |
| 72912-570 | ADHANSIA XR | methylphenidate hydrochloride Extented Release Capsules | Adlon Therapeutics L.P. | NDA | Current |
| 72912-570 | ADHANSIA XR | methylphenidate hydrochloride | Adlon Therapeutics L.P. | NDA | Current |
| 72912-570 | ADHANSIA XR | methylphenidate hydrochloride | Adlon Therapeutics L.P. | NDA | Current |
| 72912-570 | ADHANSIA XR | methylphenidate hydrochloride | Adlon Therapeutics L.P. | NDA | Current |
| 72912-570 | ADHANSIA XR | methylphenidate hydrochloride | Adlon Therapeutics L.P. | NDA | Current |
| 72912-570 | ADHANSIA XR | methylphenidate hydrochloride | Adlon Therapeutics L.P. | NDA | Current |
| 72912-585 | ADHANSIA XR | methylphenidate hydrochloride | Adlon Therapeutics L.P. | NDA | Current |
| 72912-585 | ADHANSIA XR | methylphenidate hydrochloride | Adlon Therapeutics L.P. | NDA | Current |
| 72912-585 | ADHANSIA XR | methylphenidate hydrochloride Extented Release Capsules | Adlon Therapeutics L.P. | NDA | Current |
| 72912-585 | ADHANSIA XR | methylphenidate hydrochloride | Adlon Therapeutics L.P. | NDA | Current |
| 72912-585 | ADHANSIA XR | methylphenidate hydrochloride | Adlon Therapeutics L.P. | NDA | Current |
| 72912-585 | ADHANSIA XR | methylphenidate hydrochloride | Adlon Therapeutics L.P. | NDA | Current |
| 72912-585 | ADHANSIA XR | methylphenidate hydrochloride | Adlon Therapeutics L.P. | NDA | Current |
| 72912-585 | ADHANSIA XR | methylphenidate hydrochloride | Adlon Therapeutics L.P. | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 67992 | SUPPL | 2021-06-30 |
| 67991 | SUPPL | 2021-06-30 |
| 69277 | SUPPL | 2021-06-29 |
| 67960 | SUPPL | 2021-06-29 |
| 67927 | SUPPL | 2021-06-28 |
| 67926 | SUPPL | 2021-06-28 |
| 59295 | SUPPL | 2019-07-10 |
| 59294 | SUPPL | 2019-07-10 |
| 59248 | SUPPL | 2019-07-05 |
| 59229 | ORIG | 2019-07-03 |
| 57828 | ORIG | 2019-02-28 |
| 57827 | ORIG | 2019-02-27 |
| 64328 | ORIG | 1900-01-01 |
| 64327 | ORIG | 1900-01-01 |
| 63147 | ORIG | 1900-01-01 |
| 63146 | ORIG | 1900-01-01 |
| 63145 | ORIG | 1900-01-01 |